461 related articles for article (PubMed ID: 15078817)
1. p27Kip1 modulates cell migration through the regulation of RhoA activation.
Besson A; Gurian-West M; Schmidt A; Hall A; Roberts JM
Genes Dev; 2004 Apr; 18(8):862-76. PubMed ID: 15078817
[TBL] [Abstract][Full Text] [Related]
2. Oxidized LDL induces proliferation and hypertrophy in human umbilical vein endothelial cells via regulation of p27Kip1 expression: role of RhoA.
Seibold S; Schürle D; Heinloth A; Wolf G; Wagner M; Galle J
J Am Soc Nephrol; 2004 Dec; 15(12):3026-34. PubMed ID: 15579505
[TBL] [Abstract][Full Text] [Related]
3. Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1).
Martín A; Odajima J; Hunt SL; Dubus P; Ortega S; Malumbres M; Barbacid M
Cancer Cell; 2005 Jun; 7(6):591-8. PubMed ID: 15950907
[TBL] [Abstract][Full Text] [Related]
4. Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells.
Koga H; Harada M; Ohtsubo M; Shishido S; Kumemura H; Hanada S; Taniguchi E; Yamashita K; Kumashiro R; Ueno T; Sata M
Hepatology; 2003 May; 37(5):1086-96. PubMed ID: 12717389
[TBL] [Abstract][Full Text] [Related]
5. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells.
Mann DJ; Higgins T; Jones NC; Rozengurt E
Oncogene; 1997 Apr; 14(15):1759-66. PubMed ID: 9150381
[TBL] [Abstract][Full Text] [Related]
6. Cyclin dependent kinase inhibitor p27(Kip1) is upregulated by hypoxia via an ARNT dependent pathway.
Wang G; Reisdorph R; Clark RE; Miskimins R; Lindahl R; Miskimins WK
J Cell Biochem; 2003 Oct; 90(3):548-60. PubMed ID: 14523989
[TBL] [Abstract][Full Text] [Related]
7. Opposing roles for p21(waf1/cip1) and p27(kip1) in enterocyte differentiation, proliferation, and migration.
Stehr W; Mercer TI; Bernal NP; Erwin CR; Warner BW
Surgery; 2005 Aug; 138(2):187-94. PubMed ID: 16153426
[TBL] [Abstract][Full Text] [Related]
8. A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression.
Boehm M; Yoshimoto T; Crook MF; Nallamshetty S; True A; Nabel GJ; Nabel EG
EMBO J; 2002 Jul; 21(13):3390-401. PubMed ID: 12093740
[TBL] [Abstract][Full Text] [Related]
9. Quantification of the cell-cycle inhibitors p27(Kip1) and p21(Cip1) in human atherectomy specimens: primary stenosis versus restenosis.
Braun-Dullaeus RC; Ziegler A; Bohle RM; Bauer E; Hein S; Tillmanns H; Haberbosch W
J Lab Clin Med; 2003 Mar; 141(3):179-89. PubMed ID: 12624599
[TBL] [Abstract][Full Text] [Related]
10. Persistent and heterogenous expression of the cyclin-dependent kinase inhibitor, p27KIP1, in rat hearts during development.
Koh KN; Kang MJ; Frith-Terhune A; Park SK; Kim I; Lee CO; Koh GY
J Mol Cell Cardiol; 1998 Mar; 30(3):463-74. PubMed ID: 9515024
[TBL] [Abstract][Full Text] [Related]
11. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
12. The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression.
Cappellini A; Tabellini G; Zweyer M; Bortul R; Tazzari PL; Billi AM; Falà F; Cocco L; Martelli AM
Leukemia; 2003 Nov; 17(11):2157-67. PubMed ID: 12931221
[TBL] [Abstract][Full Text] [Related]
13. RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors.
Zhang S; Tang Q; Xu F; Xue Y; Zhen Z; Deng Y; Liu M; Chen J; Liu S; Qiu M; Liao Z; Li Z; Luo D; Shi F; Zheng Y; Bi F
Mol Cancer Res; 2009 Apr; 7(4):570-80. PubMed ID: 19372585
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
Salatino M; Labriola L; Schillaci R; Charreau EH; Elizalde PV
Exp Cell Res; 2001 Apr; 265(1):152-66. PubMed ID: 11281653
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 induction of cellular migration requires p27(KIP1).
Li Z; Jiao X; Wang C; Ju X; Lu Y; Yuan L; Lisanti MP; Katiyar S; Pestell RG
Cancer Res; 2006 Oct; 66(20):9986-94. PubMed ID: 17047061
[TBL] [Abstract][Full Text] [Related]
16. p27(Kip1) is important in modulating pulmonary artery smooth muscle cell proliferation.
Fouty BW; Grimison B; Fagan KA; Le Cras TD; Harral JW; Hoedt-Miller M; Sclafani RA; Rodman DM
Am J Respir Cell Mol Biol; 2001 Nov; 25(5):652-8. PubMed ID: 11713109
[TBL] [Abstract][Full Text] [Related]
17. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
Touyz RM; Yao G
J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
[TBL] [Abstract][Full Text] [Related]
18. Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus.
Mann DJ; Child ES; Swanton C; Laman H; Jones N
EMBO J; 1999 Feb; 18(3):654-63. PubMed ID: 9927425
[TBL] [Abstract][Full Text] [Related]
19. A novel protein associated with membrane-type 1 matrix metalloproteinase binds p27(kip1) and regulates RhoA activation, actin remodeling, and matrigel invasion.
Hoshino D; Tomari T; Nagano M; Koshikawa N; Seiki M
J Biol Chem; 2009 Oct; 284(40):27315-26. PubMed ID: 19654316
[TBL] [Abstract][Full Text] [Related]
20. Oligodendrocyte lineage transcription factor 2 inhibits the motility of a human glial tumor cell line by activating RhoA.
Tabu K; Ohba Y; Suzuki T; Makino Y; Kimura T; Ohnishi A; Sakai M; Watanabe T; Tanaka S; Sawa H
Mol Cancer Res; 2007 Oct; 5(10):1099-109. PubMed ID: 17951409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
